Pyott David E I exercised Options tied to Tarsus Pharmaceuticals on 2026-09-15, leaving him with 9,575 shares and representing about 2.1% of his resulting share holding. The exercise also represented about 24.9% of his prior derivative securities holding, giving investors two stated measures of the position change.

Key Highlights

  • Pyott David E I’s option exercise left him with 9,575 Tarsus Pharmaceuticals shares.
  • The exercise represented about 24.9% of his prior derivative securities holding.
  • The Tarsus Pharmaceuticals transaction represented about 2.1% of Pyott David E I’s resulting share holding.

Pyott David E I exercised options tied to Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) on 15 September 2026, leaving him with 9,575 shares. The transaction represented about 2.1% of his resulting share holding.

Tarsus Option Exercise Recorded on 15 September 2026

Pyott David E I is identified as a director of Tarsus Pharmaceuticals. The transaction involved options for Tarsus Pharmaceuticals shares and derivative securities. The post-transaction share position stood at 9,575. The reported transaction percentage for that holding was about 2.1%.

Derivative Position Measured Against Prior Holding

The transaction also represented about 24.9% of Pyott David E I’s prior derivative securities holding in Tarsus Pharmaceuticals. That percentage applies to the derivative securities position rather than the resulting share holding. Tarsus Pharmaceuticals is the named issuer associated with both positions.